Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Louis Januzzi Jr., M.D.

Co-Author

Back to Details
This page shows the publications co-authored by James Januzzi and Cian McCarthy.
James Januzzi
Connection Strength
18.604
Cian McCarthy
  1. Periprocedural MI as an Endpoint in Clinical Trials: A Proposed Path Forward. J Am Coll Cardiol. 2022 02 15; 79(6):527-529.
    View in: PubMed
    Score: 0.987
  2. Untangling Myocardial Injury: Moving From Consequence to Cause. J Am Coll Cardiol. 2021 08 24; 78(8):791-793.
    View in: PubMed
    Score: 0.955
  3. Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction. J Am Coll Cardiol. 2021 02 23; 77(7):848-857.
    View in: PubMed
    Score: 0.922
  4. Increasingly Sensitive Troponin Assays: Is Perfect the Enemy of Good? J Am Heart Assoc. 2020 12; 9(23):e019678.
    View in: PubMed
    Score: 0.907
  5. Derivation and External Validation of a High-Sensitivity Cardiac Troponin-Based Proteomic Model to Predict the Presence of Obstructive Coronary Artery Disease. J Am Heart Assoc. 2020 08 18; 9(16):e017221.
    View in: PubMed
    Score: 0.888
  6. Cardiac Troponin and the True False Positive. JACC Case Rep. 2020 Mar; 2(3):461-463.
    View in: PubMed
    Score: 0.864
  7. Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin Assays: A Practical Approach for Clinicians. JAMA Cardiol. 2019 10 01; 4(10):1034-1042.
    View in: PubMed
    Score: 0.837
  8. Passivating High-Risk Plaques: Try, Try Again. JACC Cardiovasc Imaging. 2020 07; 13(7):1561-1563.
    View in: PubMed
    Score: 0.830
  9. Trivializing an Elevated Troponin: Adding Insult to Injury? J Am Coll Cardiol. 2019 01 08; 73(1):10-12.
    View in: PubMed
    Score: 0.796
  10. Type 2 Myocardial Infarction and the Hospital Readmission Reduction Program. J Am Coll Cardiol. 2018 09 04; 72(10):1166-1170.
    View in: PubMed
    Score: 0.777
  11. Type 2 Myocardial Infarction-Diagnosis, Prognosis, and Treatment. JAMA. 2018 Aug 07; 320(5):433-434.
    View in: PubMed
    Score: 0.773
  12. A clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study. Clin Cardiol. 2018 Jul; 41(7):903-909.
    View in: PubMed
    Score: 0.765
  13. Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study. J Am Heart Assoc. 2018 03 08; 7(6).
    View in: PubMed
    Score: 0.751
  14. Evaluating Chest Pain in the Emergency Department: Searching for the Optimal Gatekeeper. J Am Coll Cardiol. 2018 02 13; 71(6):617-619.
    View in: PubMed
    Score: 0.748
  15. Soluble ST2 in Heart Failure. Heart Fail Clin. 2018 Jan; 14(1):41-48.
    View in: PubMed
    Score: 0.742
  16. Biomarkers in stable coronary artery disease. Am Heart J. 2018 02; 196:82-96.
    View in: PubMed
    Score: 0.733
  17. Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study). Am J Cardiol. 2017 07 01; 120(1):25-32.
    View in: PubMed
    Score: 0.705
  18. Relation of High-Sensitivity Cardiac Troponin I and Obstructive Coronary Artery Disease in Patients Without Acute Myocardial Infarction. Am J Cardiol. 2022 Mar 28.
    View in: PubMed
    Score: 0.249
  19. Hospitalizations and Outcomes of T1MI Observed Before and After the Introduction of MI Subtype Codes. J Am Coll Cardiol. 2021 09 21; 78(12):1242-1253.
    View in: PubMed
    Score: 0.240
  20. The Intersection of Type 2 Myocardial Infarction and Heart Failure. J Am Heart Assoc. 2021 09 07; 10(17):e020849.
    View in: PubMed
    Score: 0.239
  21. A Test in Context: Interpretation of High-Sensitivity Cardiac Troponin Assays in Different Clinical Settings. J Am Coll Cardiol. 2021 03 16; 77(10):1357-1367.
    View in: PubMed
    Score: 0.232
  22. Cardiologist Evaluation of Patients With Type 2 Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2021 01; 14(1):e007440.
    View in: PubMed
    Score: 0.226
  23. Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system. EClinicalMedicine. 2020 Sep; 26:100504.
    View in: PubMed
    Score: 0.223
  24. Home-Time After Discharge Among Patients With Type 2 Myocardial Infarction. J Am Heart Assoc. 2020 05 18; 9(10):e015978.
    View in: PubMed
    Score: 0.218
  25. Inflammation in Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 03 24; 75(11):1324-1340.
    View in: PubMed
    Score: 0.216
  26. Sex Differences in Patient Characteristics, Treatment Strategies, and Outcomes for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2019 06 25; 73(24):3230-3232.
    View in: PubMed
    Score: 0.205
  27. Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death. J Am Coll Cardiol. 2019 05 07; 73(17):2135-2145.
    View in: PubMed
    Score: 0.204
  28. Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs. JAMA Cardiol. 2019 05 01; 4(5):460-464.
    View in: PubMed
    Score: 0.203
  29. Association of the New Peer Group-Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program. JAMA Netw Open. 2019 04 05; 2(4):e192987.
    View in: PubMed
    Score: 0.202
  30. Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays. J Am Coll Cardiol. 2019 03 26; 73(11):1273-1284.
    View in: PubMed
    Score: 0.202
  31. Left Ventricular Thrombus: Contemporary Etiologies, Treatment Strategies, and Outcomes. J Am Coll Cardiol. 2019 04 23; 73(15):2007-2009.
    View in: PubMed
    Score: 0.201
  32. Underutilization of Cardiac Rehabilitation for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2019 04 23; 73(15):2005-2007.
    View in: PubMed
    Score: 0.201
  33. A clinical, proteomics, and artificial intelligence-driven model to predict acute kidney injury in patients undergoing coronary angiography. Clin Cardiol. 2019 Feb; 42(2):292-298.
    View in: PubMed
    Score: 0.199
  34. Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study. Am Heart J. 2019 03; 209:36-46.
    View in: PubMed
    Score: 0.198
  35. Multiple biomarker panel to screen for severe aortic stenosis: results from the CASABLANCA study. Open Heart. 2018; 5(2):e000916.
    View in: PubMed
    Score: 0.196
  36. Endothelin-1 Measurement in Patients Undergoing Diagnostic Coronary Angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study. Clin Chem. 2018 11; 64(11):1617-1625.
    View in: PubMed
    Score: 0.195
  37. Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment. JAMA Cardiol. 2018 07 01; 3(7):642-649.
    View in: PubMed
    Score: 0.192
  38. Type 2 Myocardial Infarction - An Evolving Entity. Circ J. 2018 01 25; 82(2):309-315.
    View in: PubMed
    Score: 0.186
  39. Application of the GRACE, TIMI, and TARRACO Risk Scores in Type 2 Myocardial Infarction. J Am Coll Cardiol. 2020 01 28; 75(3):344-345.
    View in: PubMed
    Score: 0.053
  40. Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists. J Am Coll Cardiol. 2019 04 02; 73(12):1596-1598.
    View in: PubMed
    Score: 0.051
  41. Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling. J Am Coll Cardiol. 2018 12 25; 72(25):3370-3372.
    View in: PubMed
    Score: 0.050
  42. Delirium in the Cardiac Intensive Care Unit. J Am Heart Assoc. 2018 02 16; 7(4).
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.